Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised phase II study of pegfilgrastim timing after autologous blood stem cell transplantation
2006-003682-14Phase 2Completed
- Sponsor
- GMIHO
- Start
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of pegfilgrastim in leukemia, lymphoma and multiple myeloma (MM) (2 arms), sponsored by GMIHO. Primary endpoint: Time to granulocyte recovery. Started Feb 2007; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
leukemialymphomamultiple myeloma (MM)
Beyond the preview
Go deeper on 2006-003682-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003682-14.